✦ LIBER ✦

The Effect of Mesencephalic Lesions on Tyramine and Dopamine in the Caudate Nucleus of the Rat

✍ Scribed by A. V. Juorio; R. S. G. Jones

Book ID: 111171672
Publisher: John Wiley and Sons
Year: 1981
Tongue: English
Weight: 640 KB
Volume: 36
Category: Article
ISSN: 0022-3042
DOI: 10.1111/j.1471-4159.1981.tb10813.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phenylalanine in the caudate nucleus of

Phenylalanine in the caudate nucleus of dopamine depleted rats

✍ P. R. Paetsch; A. J. Greenshaw; A. V. Juorio 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 426 KB

Uptake ofpara-tyramine andmeta-tyramine

Uptake ofpara-tyramine andmeta-tyramine into slices of the caudate nucleus and hypothalamus of the rat

✍ Elena H. Petrali; Alan A. Boulton; Lillian E. Dyck 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 507 KB

The effect of raphé nuclei lesions on st

The effect of raphé nuclei lesions on striatal tyramine concentration and dopamine turnover in the rat

✍ A. V. Juorio; A. J. Greenshaw 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 339 KB

Changes in Levels of Dopamine and Tyrami

Changes in Levels of Dopamine and Tyramine in the Rat Caudate Nucleus Following Alterations of Impulse Flow in the Nigrostriatal Pathway

✍ R. S. G. Jones; A. V. Juorio; A. A. Boulton 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 574 KB

CHARACTERIZATION OF A DOPAMINE-SENSITIVE

CHARACTERIZATION OF A DOPAMINE-SENSITIVE ADENYLATE CYCLASE IN THE RAT CAUDATE NUCLEUS

✍ Yvonne C. Clement-Cormier; R. G. Parrish; G. L. Petzold; J. W. Kebabian; P. Gree 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB

Effect of acute and chronic fluoxetine o

Effect of acute and chronic fluoxetine on extracellular dopamine levels in the caudate-putamen and nucleus accumbens of rat

✍ Robert N. Clark; Charles R. Ashby Jr.; Stephen L. Dewey; P. Veeraraghavan Ramach 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 710 KB

Recent studies indicate that an increase in serotonergic (5-HT) activity in the nucleus accumbens (NAc) produces an increase in dopamine (DA) release, providing a possible mechanism for the involvement of DA in the therapeutic action of selective serotonin reuptake inhibitor (SSRI) antidepressants.